» Articles » PMID: 23328525

Mortality by Level of Emphysema and Airway Wall Thickness

Overview
Specialty Critical Care
Date 2013 Jan 19
PMID 23328525
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: There is limited knowledge of the prognostic value of quantitative computed tomography (CT) measures of emphysema and airway wall thickness (AWT) on mortality.

Objectives: To examine 8-year mortality in relation to CT-measured emphysema and AWT, and assess if potential impact of these predictors remained after adjustment for lung function.

Methods: In the Norwegian GenKOLS study of 2003-2005, 947 ever-smokers (49% with COPD) aged 40-85 years performed spirometry and CT examination. Mortality data from 2003-2011 were gathered from the Norwegian Cause of Death Registry. CT emphysema % low-attenuation areas (%LAA) and standardized measure for AWT (AWT-Pi10) were main predictors. We performed Laplace regression for survival data, estimating survival time for specified population percentiles within each emphysema category. Models were adjusted for sex, FEV1, COPD status, age, body mass index, smoking, and inflation level.

Measurements And Main Results: During 8-year follow-up all-cause mortality rate was 15%. Although 4% of the subjects with %LAA less than 3 died, 18% with %LAA 3-10 and 44% with %LAA greater than or equal to 10 died. After adjustment, the comparable percentile subjects with medium and high emphysema had 19 months shorter survival than subjects who died in the lowest emphysema category. Subjects with %LAA greater than or equal to 10 had 33 and 37 months shorter survival than the lowest emphysema category with regard to respiratory and cardiovascular mortality, respectively. No significant associations were found between %LAA and cancer and lung cancer mortality. AWT did not predict mortality independently, but a positive interaction with emphysema was observed.

Conclusions: AWT affected mortality with increasing degree of emphysema, whereas CT measure of emphysema was a strong independent mortality predictor.

Citing Articles

What is worth measuring in patients with COPD?.

Tantucci C Multidiscip Respir Med. 2025; 20.

PMID: 39899024 PMC: 11875688. DOI: 10.5826/mrm.2025.1010.


Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.

Takano T, Tsubouchi K, Hamada N, Ichiki K, Torii R, Takata S BMC Pulm Med. 2024; 24(1):556.

PMID: 39506773 PMC: 11539611. DOI: 10.1186/s12890-024-03347-5.


3D airway geometry analysis of factors in airway navigation failure for lung nodules.

Cho H, Choe J, Kim J, Oh Y, Park H, Lee K Cancer Imaging. 2024; 24(1):84.

PMID: 38965621 PMC: 11223435. DOI: 10.1186/s40644-024-00730-7.


Comparison of Virtual Non-Contrast and True Non-Contrast CT Images Obtained by Dual-Layer Spectral CT in COPD Patients.

Steinhardt M, Marka A, Ziegelmayer S, Makowski M, Braren R, Graf M Bioengineering (Basel). 2024; 11(4).

PMID: 38671723 PMC: 11047621. DOI: 10.3390/bioengineering11040301.


Differential decline of lung function in COPD patients according to structural abnormality in chest CT.

Lee H, Lee J, Kim Y, Jang A, Hwang Y, Lee J Heliyon. 2024; 10(7):e27683.

PMID: 38560191 PMC: 10980934. DOI: 10.1016/j.heliyon.2024.e27683.